Home Newsfeeds Authorizes Moderna, Pfizer-BioNTech Bivalent Covid-19 Vaccines For Use As A Booster Dose

Authorizes Moderna, Pfizer-BioNTech Bivalent Covid-19 Vaccines For Use As A Booster Dose

– U.S. FDA- U.S. FDA

byBenzinga Newsdesk

August 31, 2022

1 minute read

– U.S. FDA

Floor & Decor Set For Strong 2025: Analyst Highlights Potential Turnaround And Market Share Gains

By Shivani Kumaresan

November 20, 3:09 PM

Truist Securities analyst Keith Hughes reiterated a Buy rating on the shares of Floor & Decor Holdings Inc (NYSE: FND) and raised the price target from $97 to $102.

FND

IHS Holding Q3 EPS $(0.14) Down From $(0.10) YoY, Sales $521.30M Beat $485.56M Estimate

By Bill Haddad

November 15, 7:43 AM

IHS Holding (NYSE:IHS) reported quarterly losses of $(0.14) per share. This is a 40 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $521.30

IHS

Morgan Stanley Maintains Overweight on Gaming and Leisure Props, Raises Price Target to $55

By Benzinga Newsdesk

December 16, 9:56 AM

Morgan Stanley analyst Ronald Kamdem maintains Gaming and Leisure Props (NASDAQ:GLPI) with a Overweight and raises the price target from $54 to $55.

GLPI

BMO Capital Maintains Outperform on GoGold Resources, Lowers Price Target to C$3.5

By Benzinga Newsdesk

July 14, 6:51 AM

BMO Capital analyst Ryan Thompson maintains GoGold Resources (TSX:GGD) with a Outperform and lowers the price target from C$4.1 to C$3.5.

TSX:GGD

Authorizes Moderna, Pfizer-BioNTech Bivalent Covid-19 Vaccines For Use As A Booster Dose

Related Posts

Floor & Decor Set For Strong 2025: Analyst Highlights Potential Turnaround And Market Share Gains

IHS Holding Q3 EPS $(0.14) Down From $(0.10) YoY, Sales $521.30M Beat $485.56M Estimate

Morgan Stanley Maintains Overweight on Gaming and Leisure Props, Raises Price Target to $55

BMO Capital Maintains Outperform on GoGold Resources, Lowers Price Target to C$3.5